Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales, and Northern Ireland: Where are we now?

Sexually Transmitted Infections

Volumn 82, Issue 1, 2006, Pages 4-10

  Brown, Alison E ^a   Tomkins, S E ^a   Logan, L E ^a   Lamontagne, D S ^a   Munro, H L ^a   Hope, V D ^a,b   Righarts, A ^a   Blackham, J E ^a   Rice, B D ^a   Chadborn, T R ^a   Tookey, P A ^c   Parry, J V ^a   Delpech, V ^a   Gill, O N ^a   Fenton, K A ^a,d  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADULT; CHLAMYDIA; DISEASE TRANSMISSION; FEMALE; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MONITORING; PREVENTION STUDY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SCREENING; SECONDARY PREVENTION; SEXUALLY TRANSMITTED DISEASE; UNITED KINGDOM; VACCINATION;

EID: 33144456706     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2005.016386     Document Type: Review

References (30)

1. Carosi G, Torti C. "Solving the puzzle" of current HAART: what key strategic trials are needed? New Microbiol 2004;27:127-30.
2. Department of Health. The national strategy for sexual health and HIV. London: Department of Health, 2001.
3. Scott P, Anrold E, Evans B, et al. Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000. J Antimicrob Chemother 2004;53:469-73.
4. Office of Health Economics. Cost of treatment for sexually transmitted diseases. London: Office of Health Economics, 1995.
5. Cates W, Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequalae. Am J Obstet Gynaecol 1991;164:1771-81.
6. Nusbaum MR, Wallace RR, Slatt LM, et al. Sexually transmitted infections and increased risk of co-infection with human immunodeficiency virus. J Am Osteopath Assoc 2004;104:527-35.
7. The UK Collaborative Group for HIV and STI surveillance. Focus on prevention. HIV and other sexually transmitted infections in the United Kingdom in 2003. London: Health Protection Agency Centre for Infections, November, 2004.
8. Ades AE, Davidson CF, Holland FJ, et al. Vertically transmitted HIV infection in the British Isles. BMJ 1993;206:1296.
9. Nicoll A, Gill ON, Peckham CS, et al. The public health applications of the unlinked anonymous seroprevalence monitoring programme for HIV in the United Kingdom. Int J Epidemiol 2000;29:1-10.
10. Catchpole MA, McGarrigle CA, Rogers PA, et al. Serosurveillance of prevalence of HIV infection in homosexual men with acute sexually transmitted infection. BMJ 2001;321:1318-20.
11. Ades AE, Davidson CF, Holland FJ, et al. Vertically transmitted HIV infection in the British Isles. BMJ 1993;206:1296.
12. Cliffe S, Tookey PA, Nicoll A. Antenatal detection of HIV: national surveillance and unlinked anonymous survey. BMJ 2001;323:376-7.
13. Duong T, Ades A, Gibb DM, et al. Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data. BMJ 1999;319:1227-9.
14. Gupta SB, Dingley SD, Lamgni TL, et al. The national CD4 surveillance scheme for England and Wales. Commun Dis Public Health 2001;4:27-32.
15. Pozniak A, Gazzard B, Anderson J, et al. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med 2003;4(Suppl 1):1-41.
16. McHenry A, Macdonald N, Sinka K, et al. National assessment of prevalent diagnosed HIV infections. Commun Dis Public Health 2000;3:277-81.
17. Rice BD, Payne LJ, Sinka K, et al. The changing epidemiology of prevalent diagnosed HIV infections in England, Wales and Northern Ireland. Sex Transm Infect 2005;81:223-9.
18. Department of Health. National chlamydia screening programme in England-programme overview, core requirements and data collection. 2nd ed. London: DoH, 2004.
19. LaMontagne DS, Fenton KA, Randall S, et al. Establishing the national chlamydia screening programme in England: results from the first full year of screening. Sex Transm Infect 2004;80:335-41.
20. Health Protection Agency, Scottish Centre for Infection and Environmental Health, National Public Health Service for Wales, Communicable Disease Surveillance Centre Northern Ireland, Centre for Research on Drugs and Health Behaviour, Unlinked Anonymous Steering Group. Shooting up; infections among injecting drug users in the United Kingdom 2003. London: Health Protection Agency, October, 2004.
21. Chadborn TR, Baster K, Delpech VC, et al. No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales 1993-2002). AIDS, 2005 25, 19:513-20.
22. www.hpa.org.uk/infections/topics_az/hiv_and_sti/epidemiology/wtimes.htm.
23. Hope VD, Rogers PA, Jordan LF, et al. Sustained increase in the sharing of needles and syringes among drug users in England and Wales. AIDS 2002;16:2494-6.
24. White PJ, Ward H, Cassell JA, et al. Vicious and virtuous circles in the dynamics of infectious disease and the provision of health care; gonorrhea in Britain as an example. J Infect Dis 2005;192:824-36.
25. Murphy G, Charlett A, Brown AE, et al. Is HIV incidence increasing in MSM attending GUM clinics in England, Wales and Northern Ireland? Commun Dis Public Health 2004;7:11-14.
26. Brown AE, Sadler KE, Tomkins SE, et al. Recent trends in HIV and other STIs in the United Kingdom: data to the end of 2002. Sex Transm Infect 2004;80:159-66.
27. Low N, Sterne JA, Barlow D. Inequalities in rates of gonorrhoea and chlamydia between black ethnic groups in south east London: cross sectional study. Sex Transm Infect 2001;14:63-9.
28. Patel B, Chadborn TR, Rice BD, et al. Epidemiological and clinical trends in levels of antiretroviral therapy uptake, using national surveillance data (1998-2002). BHIVA conference 2004 15-17 April; 10-18.
29. McVeigh J, Beynon C, Bellis MA. New challenges for agency based syringe exchange based syringe based exchange schemes analysis of 11 years of data (1991-2001) in Merseyside and Cheshire, United Kingdom. Int J Drug Policy 2003;14:399-405.
30. Thein HH, Denoe M, van Beek I, et al. Injecting behaviour of injecting drug users at needle and syringe programmes and pharmacies in Australia. Int J Drug Policy 2003;14:399-405.